1. Home
  2. SHOO vs VCEL Comparison

SHOO vs VCEL Comparison

Compare SHOO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHOO
  • VCEL
  • Stock Information
  • Founded
  • SHOO 1990
  • VCEL 1989
  • Country
  • SHOO United States
  • VCEL United States
  • Employees
  • SHOO N/A
  • VCEL N/A
  • Industry
  • SHOO Shoe Manufacturing
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SHOO Consumer Discretionary
  • VCEL Health Care
  • Exchange
  • SHOO Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • SHOO 1.8B
  • VCEL 2.1B
  • IPO Year
  • SHOO 1993
  • VCEL 1997
  • Fundamental
  • Price
  • SHOO $26.87
  • VCEL $40.12
  • Analyst Decision
  • SHOO Hold
  • VCEL Strong Buy
  • Analyst Count
  • SHOO 7
  • VCEL 8
  • Target Price
  • SHOO $27.00
  • VCEL $62.00
  • AVG Volume (30 Days)
  • SHOO 1.5M
  • VCEL 565.6K
  • Earning Date
  • SHOO 07-30-2025
  • VCEL 07-31-2025
  • Dividend Yield
  • SHOO 3.13%
  • VCEL N/A
  • EPS Growth
  • SHOO N/A
  • VCEL 521.85
  • EPS
  • SHOO 2.32
  • VCEL 0.05
  • Revenue
  • SHOO $2,284,080,000.00
  • VCEL $238,541,000.00
  • Revenue This Year
  • SHOO $12.44
  • VCEL $23.03
  • Revenue Next Year
  • SHOO $8.22
  • VCEL $24.52
  • P/E Ratio
  • SHOO $11.58
  • VCEL $678.23
  • Revenue Growth
  • SHOO 10.34
  • VCEL 14.80
  • 52 Week Low
  • SHOO $19.05
  • VCEL $34.87
  • 52 Week High
  • SHOO $50.01
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • SHOO 58.21
  • VCEL 51.37
  • Support Level
  • SHOO $26.08
  • VCEL $34.87
  • Resistance Level
  • SHOO $27.66
  • VCEL $41.00
  • Average True Range (ATR)
  • SHOO 0.93
  • VCEL 1.77
  • MACD
  • SHOO 0.14
  • VCEL 0.21
  • Stochastic Oscillator
  • SHOO 79.21
  • VCEL 67.83

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: